Global Celiac Disease Drugs Market Research Report 2024, Forecast to 2032
Report Overview
Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.
The global Celiac Disease Drugs market size was estimated at USD 597.30 million in 2023 and is projected to reach USD 2084.84 million by 2032, exhibiting a CAGR of 14.90% during the forecast period.
North America Celiac Disease Drugs market size was estimated at USD 197.93 million in 2023, at a CAGR of 12.77% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Celiac Disease Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celiac Disease Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celiac Disease Drugs market in any manner.
Global Celiac Disease Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Market Segmentation (by Type)
First Line of Treatment
Second Line of Treatment
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celiac Disease Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celiac Disease Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.
The global Celiac Disease Drugs market size was estimated at USD 597.30 million in 2023 and is projected to reach USD 2084.84 million by 2032, exhibiting a CAGR of 14.90% during the forecast period.
North America Celiac Disease Drugs market size was estimated at USD 197.93 million in 2023, at a CAGR of 12.77% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Celiac Disease Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celiac Disease Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celiac Disease Drugs market in any manner.
Global Celiac Disease Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Market Segmentation (by Type)
First Line of Treatment
Second Line of Treatment
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Celiac Disease Drugs Market
- Overview of the regional outlook of the Celiac Disease Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celiac Disease Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Celiac Disease Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celiac Disease Drugs
1.2 Key Market Segments
1.2.1 Celiac Disease Drugs Segment by Type
1.2.2 Celiac Disease Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELIAC DISEASE DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celiac Disease Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Celiac Disease Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELIAC DISEASE DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Celiac Disease Drugs Sales by Manufacturers (2019-2024)
3.2 Global Celiac Disease Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celiac Disease Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celiac Disease Drugs Sales Sites, Area Served, Product Type
3.6 Celiac Disease Drugs Market Competitive Situation and Trends
3.6.1 Celiac Disease Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celiac Disease Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELIAC DISEASE DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Celiac Disease Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELIAC DISEASE DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELIAC DISEASE DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celiac Disease Drugs Sales Market Share by Type (2019-2024)
6.3 Global Celiac Disease Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Celiac Disease Drugs Price by Type (2019-2024)
7 CELIAC DISEASE DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celiac Disease Drugs Market Sales by Application (2019-2024)
7.3 Global Celiac Disease Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Celiac Disease Drugs Sales Growth Rate by Application (2019-2024)
8 CELIAC DISEASE DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Celiac Disease Drugs Sales by Region
8.1.1 Global Celiac Disease Drugs Sales by Region
8.1.2 Global Celiac Disease Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Celiac Disease Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Celiac Disease Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Celiac Disease Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Celiac Disease Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Celiac Disease Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CELIAC DISEASE DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Celiac Disease Drugs by Region (2019-2024)
9.2 Global Celiac Disease Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Celiac Disease Drugs Production
9.4.1 North America Celiac Disease Drugs Production Growth Rate (2019-2024)
9.4.2 North America Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Celiac Disease Drugs Production
9.5.1 Europe Celiac Disease Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Celiac Disease Drugs Production (2019-2024)
9.6.1 Japan Celiac Disease Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Celiac Disease Drugs Production (2019-2024)
9.7.1 China Celiac Disease Drugs Production Growth Rate (2019-2024)
9.7.2 China Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Celiac Disease Drugs Basic Information
10.1.2 Roche Celiac Disease Drugs Product Overview
10.1.3 Roche Celiac Disease Drugs Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Celiac Disease Drugs SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Merck
10.2.1 Merck Celiac Disease Drugs Basic Information
10.2.2 Merck Celiac Disease Drugs Product Overview
10.2.3 Merck Celiac Disease Drugs Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Celiac Disease Drugs SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Celiac Disease Drugs Basic Information
10.3.2 Johnson and Johnson Celiac Disease Drugs Product Overview
10.3.3 Johnson and Johnson Celiac Disease Drugs Product Market Performance
10.3.4 Johnson and Johnson Celiac Disease Drugs SWOT Analysis
10.3.5 Johnson and Johnson Business Overview
10.3.6 Johnson and Johnson Recent Developments
10.4 BiolineRx
10.4.1 BiolineRx Celiac Disease Drugs Basic Information
10.4.2 BiolineRx Celiac Disease Drugs Product Overview
10.4.3 BiolineRx Celiac Disease Drugs Product Market Performance
10.4.4 BiolineRx Business Overview
10.4.5 BiolineRx Recent Developments
10.5 Pfizer
10.5.1 Pfizer Celiac Disease Drugs Basic Information
10.5.2 Pfizer Celiac Disease Drugs Product Overview
10.5.3 Pfizer Celiac Disease Drugs Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Innovate Biopharmaceuticals
10.6.1 Innovate Biopharmaceuticals Celiac Disease Drugs Basic Information
10.6.2 Innovate Biopharmaceuticals Celiac Disease Drugs Product Overview
10.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Product Market Performance
10.6.4 Innovate Biopharmaceuticals Business Overview
10.6.5 Innovate Biopharmaceuticals Recent Developments
10.7 ImmusanT
10.7.1 ImmusanT Celiac Disease Drugs Basic Information
10.7.2 ImmusanT Celiac Disease Drugs Product Overview
10.7.3 ImmusanT Celiac Disease Drugs Product Market Performance
10.7.4 ImmusanT Business Overview
10.7.5 ImmusanT Recent Developments
10.8 Novartis
10.8.1 Novartis Celiac Disease Drugs Basic Information
10.8.2 Novartis Celiac Disease Drugs Product Overview
10.8.3 Novartis Celiac Disease Drugs Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 Bristol-Myers Squibb
10.9.1 Bristol-Myers Squibb Celiac Disease Drugs Basic Information
10.9.2 Bristol-Myers Squibb Celiac Disease Drugs Product Overview
10.9.3 Bristol-Myers Squibb Celiac Disease Drugs Product Market Performance
10.9.4 Bristol-Myers Squibb Business Overview
10.9.5 Bristol-Myers Squibb Recent Developments
10.10 Immunomedics
10.10.1 Immunomedics Celiac Disease Drugs Basic Information
10.10.2 Immunomedics Celiac Disease Drugs Product Overview
10.10.3 Immunomedics Celiac Disease Drugs Product Market Performance
10.10.4 Immunomedics Business Overview
10.10.5 Immunomedics Recent Developments
11 CELIAC DISEASE DRUGS MARKET FORECAST BY REGION
11.1 Global Celiac Disease Drugs Market Size Forecast
11.2 Global Celiac Disease Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celiac Disease Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Celiac Disease Drugs Market Size Forecast by Region
11.2.4 South America Celiac Disease Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Celiac Disease Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Celiac Disease Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Celiac Disease Drugs by Type (2025-2032)
12.1.2 Global Celiac Disease Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Celiac Disease Drugs by Type (2025-2032)
12.2 Global Celiac Disease Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Celiac Disease Drugs Sales (K Units) Forecast by Application
12.2.2 Global Celiac Disease Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celiac Disease Drugs
1.2 Key Market Segments
1.2.1 Celiac Disease Drugs Segment by Type
1.2.2 Celiac Disease Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELIAC DISEASE DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celiac Disease Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Celiac Disease Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELIAC DISEASE DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Celiac Disease Drugs Sales by Manufacturers (2019-2024)
3.2 Global Celiac Disease Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celiac Disease Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celiac Disease Drugs Sales Sites, Area Served, Product Type
3.6 Celiac Disease Drugs Market Competitive Situation and Trends
3.6.1 Celiac Disease Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celiac Disease Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELIAC DISEASE DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Celiac Disease Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELIAC DISEASE DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELIAC DISEASE DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celiac Disease Drugs Sales Market Share by Type (2019-2024)
6.3 Global Celiac Disease Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Celiac Disease Drugs Price by Type (2019-2024)
7 CELIAC DISEASE DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celiac Disease Drugs Market Sales by Application (2019-2024)
7.3 Global Celiac Disease Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Celiac Disease Drugs Sales Growth Rate by Application (2019-2024)
8 CELIAC DISEASE DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Celiac Disease Drugs Sales by Region
8.1.1 Global Celiac Disease Drugs Sales by Region
8.1.2 Global Celiac Disease Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Celiac Disease Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Celiac Disease Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Celiac Disease Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Celiac Disease Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Celiac Disease Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CELIAC DISEASE DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Celiac Disease Drugs by Region (2019-2024)
9.2 Global Celiac Disease Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Celiac Disease Drugs Production
9.4.1 North America Celiac Disease Drugs Production Growth Rate (2019-2024)
9.4.2 North America Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Celiac Disease Drugs Production
9.5.1 Europe Celiac Disease Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Celiac Disease Drugs Production (2019-2024)
9.6.1 Japan Celiac Disease Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Celiac Disease Drugs Production (2019-2024)
9.7.1 China Celiac Disease Drugs Production Growth Rate (2019-2024)
9.7.2 China Celiac Disease Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Celiac Disease Drugs Basic Information
10.1.2 Roche Celiac Disease Drugs Product Overview
10.1.3 Roche Celiac Disease Drugs Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Celiac Disease Drugs SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Merck
10.2.1 Merck Celiac Disease Drugs Basic Information
10.2.2 Merck Celiac Disease Drugs Product Overview
10.2.3 Merck Celiac Disease Drugs Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Celiac Disease Drugs SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Celiac Disease Drugs Basic Information
10.3.2 Johnson and Johnson Celiac Disease Drugs Product Overview
10.3.3 Johnson and Johnson Celiac Disease Drugs Product Market Performance
10.3.4 Johnson and Johnson Celiac Disease Drugs SWOT Analysis
10.3.5 Johnson and Johnson Business Overview
10.3.6 Johnson and Johnson Recent Developments
10.4 BiolineRx
10.4.1 BiolineRx Celiac Disease Drugs Basic Information
10.4.2 BiolineRx Celiac Disease Drugs Product Overview
10.4.3 BiolineRx Celiac Disease Drugs Product Market Performance
10.4.4 BiolineRx Business Overview
10.4.5 BiolineRx Recent Developments
10.5 Pfizer
10.5.1 Pfizer Celiac Disease Drugs Basic Information
10.5.2 Pfizer Celiac Disease Drugs Product Overview
10.5.3 Pfizer Celiac Disease Drugs Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Innovate Biopharmaceuticals
10.6.1 Innovate Biopharmaceuticals Celiac Disease Drugs Basic Information
10.6.2 Innovate Biopharmaceuticals Celiac Disease Drugs Product Overview
10.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Product Market Performance
10.6.4 Innovate Biopharmaceuticals Business Overview
10.6.5 Innovate Biopharmaceuticals Recent Developments
10.7 ImmusanT
10.7.1 ImmusanT Celiac Disease Drugs Basic Information
10.7.2 ImmusanT Celiac Disease Drugs Product Overview
10.7.3 ImmusanT Celiac Disease Drugs Product Market Performance
10.7.4 ImmusanT Business Overview
10.7.5 ImmusanT Recent Developments
10.8 Novartis
10.8.1 Novartis Celiac Disease Drugs Basic Information
10.8.2 Novartis Celiac Disease Drugs Product Overview
10.8.3 Novartis Celiac Disease Drugs Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 Bristol-Myers Squibb
10.9.1 Bristol-Myers Squibb Celiac Disease Drugs Basic Information
10.9.2 Bristol-Myers Squibb Celiac Disease Drugs Product Overview
10.9.3 Bristol-Myers Squibb Celiac Disease Drugs Product Market Performance
10.9.4 Bristol-Myers Squibb Business Overview
10.9.5 Bristol-Myers Squibb Recent Developments
10.10 Immunomedics
10.10.1 Immunomedics Celiac Disease Drugs Basic Information
10.10.2 Immunomedics Celiac Disease Drugs Product Overview
10.10.3 Immunomedics Celiac Disease Drugs Product Market Performance
10.10.4 Immunomedics Business Overview
10.10.5 Immunomedics Recent Developments
11 CELIAC DISEASE DRUGS MARKET FORECAST BY REGION
11.1 Global Celiac Disease Drugs Market Size Forecast
11.2 Global Celiac Disease Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celiac Disease Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Celiac Disease Drugs Market Size Forecast by Region
11.2.4 South America Celiac Disease Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Celiac Disease Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Celiac Disease Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Celiac Disease Drugs by Type (2025-2032)
12.1.2 Global Celiac Disease Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Celiac Disease Drugs by Type (2025-2032)
12.2 Global Celiac Disease Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Celiac Disease Drugs Sales (K Units) Forecast by Application
12.2.2 Global Celiac Disease Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Celiac Disease Drugs Market Size Comparison by Region (M USD)
Table 5. Global Celiac Disease Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Celiac Disease Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Celiac Disease Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Celiac Disease Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2022)
Table 10. Global Market Celiac Disease Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Celiac Disease Drugs Sales Sites and Area Served
Table 12. Manufacturers Celiac Disease Drugs Product Type
Table 13. Global Celiac Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Celiac Disease Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celiac Disease Drugs Market Challenges
Table 22. Global Celiac Disease Drugs Sales by Type (K Units)
Table 23. Global Celiac Disease Drugs Market Size by Type (M USD)
Table 24. Global Celiac Disease Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Celiac Disease Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Celiac Disease Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Celiac Disease Drugs Market Size Share by Type (2019-2024)
Table 28. Global Celiac Disease Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Celiac Disease Drugs Sales (K Units) by Application
Table 30. Global Celiac Disease Drugs Market Size by Application
Table 31. Global Celiac Disease Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Celiac Disease Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Celiac Disease Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Celiac Disease Drugs Market Share by Application (2019-2024)
Table 35. Global Celiac Disease Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Celiac Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Celiac Disease Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Celiac Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Celiac Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Celiac Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Celiac Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Celiac Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Global Celiac Disease Drugs Production (K Units) by Region (2019-2024)
Table 44. Global Celiac Disease Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Celiac Disease Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Celiac Disease Drugs Basic Information
Table 52. Roche Celiac Disease Drugs Product Overview
Table 53. Roche Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Celiac Disease Drugs SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Merck Celiac Disease Drugs Basic Information
Table 58. Merck Celiac Disease Drugs Product Overview
Table 59. Merck Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Merck Business Overview
Table 61. Merck Celiac Disease Drugs SWOT Analysis
Table 62. Merck Recent Developments
Table 63. Johnson and Johnson Celiac Disease Drugs Basic Information
Table 64. Johnson and Johnson Celiac Disease Drugs Product Overview
Table 65. Johnson and Johnson Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Johnson and Johnson Celiac Disease Drugs SWOT Analysis
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Recent Developments
Table 69. BiolineRx Celiac Disease Drugs Basic Information
Table 70. BiolineRx Celiac Disease Drugs Product Overview
Table 71. BiolineRx Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. BiolineRx Business Overview
Table 73. BiolineRx Recent Developments
Table 74. Pfizer Celiac Disease Drugs Basic Information
Table 75. Pfizer Celiac Disease Drugs Product Overview
Table 76. Pfizer Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Pfizer Business Overview
Table 78. Pfizer Recent Developments
Table 79. Innovate Biopharmaceuticals Celiac Disease Drugs Basic Information
Table 80. Innovate Biopharmaceuticals Celiac Disease Drugs Product Overview
Table 81. Innovate Biopharmaceuticals Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Innovate Biopharmaceuticals Business Overview
Table 83. Innovate Biopharmaceuticals Recent Developments
Table 84. ImmusanT Celiac Disease Drugs Basic Information
Table 85. ImmusanT Celiac Disease Drugs Product Overview
Table 86. ImmusanT Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. ImmusanT Business Overview
Table 88. ImmusanT Recent Developments
Table 89. Novartis Celiac Disease Drugs Basic Information
Table 90. Novartis Celiac Disease Drugs Product Overview
Table 91. Novartis Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Bristol-Myers Squibb Celiac Disease Drugs Basic Information
Table 95. Bristol-Myers Squibb Celiac Disease Drugs Product Overview
Table 96. Bristol-Myers Squibb Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Immunomedics Celiac Disease Drugs Basic Information
Table 100. Immunomedics Celiac Disease Drugs Product Overview
Table 101. Immunomedics Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Immunomedics Business Overview
Table 103. Immunomedics Recent Developments
Table 104. Global Celiac Disease Drugs Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Celiac Disease Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Celiac Disease Drugs Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Celiac Disease Drugs Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Celiac Disease Drugs Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Celiac Disease Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Celiac Disease Drugs Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Celiac Disease Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Celiac Disease Drugs Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Celiac Disease Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Celiac Disease Drugs Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Celiac Disease Drugs Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Celiac Disease Drugs Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Celiac Disease Drugs Market Size Comparison by Region (M USD)
Table 5. Global Celiac Disease Drugs Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Celiac Disease Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Celiac Disease Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Celiac Disease Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2022)
Table 10. Global Market Celiac Disease Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Celiac Disease Drugs Sales Sites and Area Served
Table 12. Manufacturers Celiac Disease Drugs Product Type
Table 13. Global Celiac Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Celiac Disease Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celiac Disease Drugs Market Challenges
Table 22. Global Celiac Disease Drugs Sales by Type (K Units)
Table 23. Global Celiac Disease Drugs Market Size by Type (M USD)
Table 24. Global Celiac Disease Drugs Sales (K Units) by Type (2019-2024)
Table 25. Global Celiac Disease Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Celiac Disease Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Celiac Disease Drugs Market Size Share by Type (2019-2024)
Table 28. Global Celiac Disease Drugs Price (USD/Unit) by Type (2019-2024)
Table 29. Global Celiac Disease Drugs Sales (K Units) by Application
Table 30. Global Celiac Disease Drugs Market Size by Application
Table 31. Global Celiac Disease Drugs Sales by Application (2019-2024) & (K Units)
Table 32. Global Celiac Disease Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Celiac Disease Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Celiac Disease Drugs Market Share by Application (2019-2024)
Table 35. Global Celiac Disease Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Celiac Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Global Celiac Disease Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Celiac Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 39. Europe Celiac Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Celiac Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 41. South America Celiac Disease Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Celiac Disease Drugs Sales by Region (2019-2024) & (K Units)
Table 43. Global Celiac Disease Drugs Production (K Units) by Region (2019-2024)
Table 44. Global Celiac Disease Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Celiac Disease Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Celiac Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Celiac Disease Drugs Basic Information
Table 52. Roche Celiac Disease Drugs Product Overview
Table 53. Roche Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Celiac Disease Drugs SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Merck Celiac Disease Drugs Basic Information
Table 58. Merck Celiac Disease Drugs Product Overview
Table 59. Merck Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Merck Business Overview
Table 61. Merck Celiac Disease Drugs SWOT Analysis
Table 62. Merck Recent Developments
Table 63. Johnson and Johnson Celiac Disease Drugs Basic Information
Table 64. Johnson and Johnson Celiac Disease Drugs Product Overview
Table 65. Johnson and Johnson Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Johnson and Johnson Celiac Disease Drugs SWOT Analysis
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Recent Developments
Table 69. BiolineRx Celiac Disease Drugs Basic Information
Table 70. BiolineRx Celiac Disease Drugs Product Overview
Table 71. BiolineRx Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. BiolineRx Business Overview
Table 73. BiolineRx Recent Developments
Table 74. Pfizer Celiac Disease Drugs Basic Information
Table 75. Pfizer Celiac Disease Drugs Product Overview
Table 76. Pfizer Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Pfizer Business Overview
Table 78. Pfizer Recent Developments
Table 79. Innovate Biopharmaceuticals Celiac Disease Drugs Basic Information
Table 80. Innovate Biopharmaceuticals Celiac Disease Drugs Product Overview
Table 81. Innovate Biopharmaceuticals Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Innovate Biopharmaceuticals Business Overview
Table 83. Innovate Biopharmaceuticals Recent Developments
Table 84. ImmusanT Celiac Disease Drugs Basic Information
Table 85. ImmusanT Celiac Disease Drugs Product Overview
Table 86. ImmusanT Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. ImmusanT Business Overview
Table 88. ImmusanT Recent Developments
Table 89. Novartis Celiac Disease Drugs Basic Information
Table 90. Novartis Celiac Disease Drugs Product Overview
Table 91. Novartis Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Bristol-Myers Squibb Celiac Disease Drugs Basic Information
Table 95. Bristol-Myers Squibb Celiac Disease Drugs Product Overview
Table 96. Bristol-Myers Squibb Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Immunomedics Celiac Disease Drugs Basic Information
Table 100. Immunomedics Celiac Disease Drugs Product Overview
Table 101. Immunomedics Celiac Disease Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Immunomedics Business Overview
Table 103. Immunomedics Recent Developments
Table 104. Global Celiac Disease Drugs Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Celiac Disease Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Celiac Disease Drugs Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Celiac Disease Drugs Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Celiac Disease Drugs Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Celiac Disease Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Celiac Disease Drugs Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Celiac Disease Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Celiac Disease Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Celiac Disease Drugs Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Celiac Disease Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Celiac Disease Drugs Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Celiac Disease Drugs Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Celiac Disease Drugs Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Celiac Disease Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celiac Disease Drugs Market Size (M USD), 2019-2032
Figure 5. Global Celiac Disease Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Celiac Disease Drugs Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celiac Disease Drugs Market Size by Country (M USD)
Figure 11. Celiac Disease Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Celiac Disease Drugs Revenue Share by Manufacturers in 2023
Figure 13. Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Celiac Disease Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Celiac Disease Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Celiac Disease Drugs Market Share by Type
Figure 18. Sales Market Share of Celiac Disease Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Celiac Disease Drugs by Type in 2023
Figure 20. Market Size Share of Celiac Disease Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Celiac Disease Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Celiac Disease Drugs Market Share by Application
Figure 24. Global Celiac Disease Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Celiac Disease Drugs Sales Market Share by Application in 2023
Figure 26. Global Celiac Disease Drugs Market Share by Application (2019-2024)
Figure 27. Global Celiac Disease Drugs Market Share by Application in 2023
Figure 28. Global Celiac Disease Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Celiac Disease Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Celiac Disease Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Celiac Disease Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Celiac Disease Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Celiac Disease Drugs Sales Market Share by Country in 2023
Figure 37. Germany Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Celiac Disease Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Celiac Disease Drugs Sales Market Share by Region in 2023
Figure 44. China Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Celiac Disease Drugs Sales and Growth Rate (K Units)
Figure 50. South America Celiac Disease Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Celiac Disease Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Celiac Disease Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Celiac Disease Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 65. China Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Celiac Disease Drugs Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Celiac Disease Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Celiac Disease Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Celiac Disease Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Celiac Disease Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Celiac Disease Drugs Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Celiac Disease Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celiac Disease Drugs Market Size (M USD), 2019-2032
Figure 5. Global Celiac Disease Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Celiac Disease Drugs Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celiac Disease Drugs Market Size by Country (M USD)
Figure 11. Celiac Disease Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Celiac Disease Drugs Revenue Share by Manufacturers in 2023
Figure 13. Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Celiac Disease Drugs Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Celiac Disease Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Celiac Disease Drugs Market Share by Type
Figure 18. Sales Market Share of Celiac Disease Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Celiac Disease Drugs by Type in 2023
Figure 20. Market Size Share of Celiac Disease Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Celiac Disease Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Celiac Disease Drugs Market Share by Application
Figure 24. Global Celiac Disease Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Celiac Disease Drugs Sales Market Share by Application in 2023
Figure 26. Global Celiac Disease Drugs Market Share by Application (2019-2024)
Figure 27. Global Celiac Disease Drugs Market Share by Application in 2023
Figure 28. Global Celiac Disease Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Celiac Disease Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Celiac Disease Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Celiac Disease Drugs Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Celiac Disease Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Celiac Disease Drugs Sales Market Share by Country in 2023
Figure 37. Germany Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Celiac Disease Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Celiac Disease Drugs Sales Market Share by Region in 2023
Figure 44. China Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Celiac Disease Drugs Sales and Growth Rate (K Units)
Figure 50. South America Celiac Disease Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Celiac Disease Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Celiac Disease Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Celiac Disease Drugs Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Celiac Disease Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 65. China Celiac Disease Drugs Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Celiac Disease Drugs Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Celiac Disease Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Celiac Disease Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Celiac Disease Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Celiac Disease Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Celiac Disease Drugs Market Share Forecast by Application (2025-2032)
